Statewide outreach initiatives across Northern California, Southern California, the Bay Area and the Inland Empire seeks ...

Data from pivotal Phase 3 frontMIND trial evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) selected for prestigious Plenary Abstracts SessionOral and ...

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies. The recognition highlights ...

The company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway.CHICAGO ...

Data demonstrate dose‑dependent hearing rescue across multiple mouse modelsCAMBRIDGE, Mass.--(BUSINESS ...

Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s network, supporting a sustainable path from clinical development to commercial access for therapies ...

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...

Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability. San Sebastián, Spain, May ...

Further strengthening of Poolbeg's global intellectual property portfolio11 May 2026 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core ...

Vibra to Support Expansion of MindMaze Therapeutics' Neurorehabilitation Platform across Leading U.S. Health Systems GENEVA, SWITZERLAND AND MECHANICSBURG, PENNSYLVANIA / ACCESS Newswire / May 12, ...

The group addresses the growing complexity and volume of tech-related disputesIRVINE, Calif.--(BUSINESS WIRE)--JAMS, the premier provider of alternative dispute resolution (ADR) services worldwide, ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...